Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
Pregnancy outcome following gestational exposure to azithromycin
Moumita Sarkar
, Cindy Woodland
, Gideon Koren
, Adrienne R.N. Einarson
Research output
:
Contribution to journal
›
Article
›
peer-review
103
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pregnancy outcome following gestational exposure to azithromycin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pregnancy Outcome
100%
Gestational Exposure
100%
Azithromycin
100%
Major Congenital Malformations
42%
Antibiotics
28%
First Trimester
14%
During Pregnancy
14%
Human Studies
14%
Healthcare Professionals
14%
Pregnant Women
14%
Teratogenic Risk
14%
Maternal Age
14%
Teratogenic Effects
14%
Teratogenic
14%
Gestational Age
14%
Alcohol Consumption
14%
Teratogen
14%
3-group
14%
Non-associated
14%
Evidence-based
14%
Treatment Options
14%
As(III)
14%
Cigarette Consumption
14%
Macrolide Antibiotics
14%
Chlamydia
14%
Azalide
14%
Dosing Regimen
14%
Antibiotic Efficacy
14%
Therapeutic Implications
14%
Statistically Significant Difference
14%
Fetal Safety
14%
Maternal Drinking
14%
Pharmacology, Toxicology and Pharmaceutical Science
Azithromycin
100%
Congenital Malformation
42%
Teratogenic Agent
28%
Antibiotics
28%
Antimicrobial Agent
28%
Human Study
14%
Macrolide
14%
Chlamydiae
14%
Diseases
14%